Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival (Q40287967)

19 September 2017

title

Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival (English)

1 reference

19 September 2017

1 reference

1 reference

Sun C

1 reference

19 September 2017

Shi Y

1 reference

19 September 2017

Xu LL

1 reference

19 September 2017

Nageswararao C

1 reference

19 September 2017

Davis LD

1 reference

19 September 2017

Segawa T

1 reference

19 September 2017

Dobi A

1 reference

19 September 2017

McLeod DG

1 reference

19 September 2017

Srivastava S

1 reference

19 September 2017

language of work or name

English

0 references

publication date

24 April 2006

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

page(s)

3905-3913

1 reference

Structure and function in the p53 family

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Molecular determinants of resistance to antiandrogen therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Androgen receptor--an update of mechanisms of action in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

The development of androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Molecular biology of the androgen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Androgen receptor signaling in androgen-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Mutation of the androgen receptor causes oncogenic transformation of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Epothilone induced cytotoxicity is dependent on p53 status in prostate cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Update on the diagnosis and treatment of prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Down-regulation of the prostate specific antigen promoter by p53 in human prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Molecular characterization of human prostate carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

mdm2: a bridge over the two tumour suppressors, p53 and Rb.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209424

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209424

1 reference

Dimensions Publication ID

19 September 2017

1048164952

0 references

1 reference